<p><em>前 Clear Street Group 首席财务官加强领导团队，与行业资深人士 Mark Wendland 和 Mark Toomey 并肩作战</em></p>
<p>纽约 --（商业资讯）--Tharimmune, Inc.（纳斯达克：THAR）（“Tharimmune” 或 “公司”），首家利用 Canton Coin（“CC”）支持 Canton Network 数字化传统金融市场的上市公司，今天宣布任命经验丰富的金融高管 Jacob Asbury 为首席财务官，立即生效。在此角色中，他将负责所有财务战略和运营，包括资本规划、财务管理、财务报告，以及 Tharimmune CC 财务基础设施的持续扩展。</p>
<p>Asbury 先生在资本市场、经纪和金融科技领域拥有近二十年的财务领导经验。在担任 Clear Street Group, Inc.的首席财务官后，Asbury 先生领导了一家独立顾问公司，专注于财务系统实施、报告优化和流程自动化。在职业生涯早期，Asbury 先生曾担任 Performance Flight &amp; Custom Jet Charters 和 Instinet Incorporated 的首席财务官。他拥有佛蒙特大学的学士学位。</p>
<p>“Jacob 在财务领导方面的深厚经验以及在财务运营中提供创新方法的记录，对于我们通过数字资产财务战略为股东创造价值至关重要，” Tharimmune, Inc.首席执行官 Mark Wendland 表示。“凭借他在资本市场的深厚根基和作为运营者的独特视角，Jacob 的任命标志着我们继续致力于通过 Canton Network 构建市场基础设施未来的承诺。”</p>
<p>Asbury 先生补充道：“Canton Network 有能力改变金融市场的运作方式，而 Tharimmune 已在这一演变的前沿。我很自豪能加入一个与众不同的领导团队，并期待利用我的经验帮助公司推进这些努力，为股东和 Canton 社区创造长期价值。”</p>
<p>Tharimmune 于 2025 年 11 月建立了其独特的数字资产财务（“DAT”）战略，不仅通过收购 CC 来驱动价值，还申请作为超级验证者运营，并投资于在 Canton Network 上构建的应用程序，以加速资本市场的机构效用和采用。Tharimmune 是首家也是唯一一家获得 Canton Foundation 支持的上市公司。</p>
<p><strong>关于 Tharimmune</strong></p>
<p>Tharimmune, Inc.（纳斯达克：THAR）是首家利用 Canton Coin 并支持 Canton Network 以推动机构区块链采用和金融市场数字化的上市公司。除了通过在 Canton Network 上的活动驱动价值外，Tharimmune 还从事临床阶段的生物技术研究和开发。欲了解更多信息，请访问：www.tharimmune.com。</p>
<p><strong>关于前瞻性声明的警示说明</strong></p>
<p>本新闻稿包含根据美国联邦证券法构成的 “前瞻性声明”。前瞻性声明是指除历史事实之外的陈述，包括但不限于关于认股权证行使的潜在和额外现金收益的金额、宣布的发行的预期收益使用、未来股东批准、未来公告和优先事项、对管理、公司治理、市场地位、商业战略、未来财务和运营表现的期望，以及其他计划和目标的预测或声明。</p>
<p>这些前瞻性声明基于当前的预期、估计、假设和预测，并涉及已知和未知的风险、不确定性和其他因素——其中许多超出了公司的控制——可能导致实际结果、表现或成就与这些声明所表达或暗示的结果有重大差异。可能影响实际结果的重要因素包括但不限于公司的增长战略执行能力；有效筹集和部署资本的能力；技术和竞争环境的发展；CC 的市场表现；以及在 2025 年 3 月 26 日向 SEC 提交的公司 10-K 年度报告及其他后续文件中描述的其他风险和不确定性。这些文件可在 www.sec.gov 获取。公司没有义务更新或修订任何前瞻性声明，无论是由于新信息、未来事件还是其他原因，法律要求的除外。</p>
<p><strong>Twitter/X:</strong>@TharimmuneInc</p>
<p><strong>网站：</strong> https://tharimmune.com/</p>
<p><img src="https://imageproxy.pbkrs.com/https://cts.businesswire.com/ct/CT/query-ZGlzdHJvPW54JmlkPWJ3bmV3cyZsYW5nPWVuJnNpZD1hY3FyOCZzdHk9MjAyNTEyMTI4NDE3MTZyMQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://cts.businesswire.com/ct/CT/query-ZGlzdHJvPW54JmlkPWJ3bmV3cyZsYW5nPWVuJnNpZD1hY3FyOCZzdHk9MjAyNTEyMTI4NDE3MTZyMQ"/></p>
<p>在 businesswire.com 查看源版本：https://www.businesswire.com/news/home/20251212841716/en/</p>
<p>媒体：</p>
<p>Gasthalter &amp; Co.</p>
<p>（212）257-4170</p>
<p>canton@gasthalter.com</p>
<p>投资者：</p>
<p>ir@tharimmune.com</p>
<p>来源：Tharimmune, Inc.</p>

THAR

<p>Tharimmune, Inc. 任命 Jacob Asbury 为首席财务官，以推进其 Canton Coin 财务战略。Asbury 拥有丰富的财务领导经验，将负责财务战略和运营。他的任命标志着 Tharimmune 对通过 Canton Network 建设市场基础设施的承诺。该公司旨在通过利用数字资产财务战略，为股东和 Canton 社区创造长期价值</p>

<p><em>Former Clear Street Group CFO Strengthens Leadership Team Alongside Industry Veterans Mark Wendland and Mark Toomey</em></p>
<div class="lb-trans"><p><em>前 Clear Street Group 首席财务官加强领导团队，与行业资深人士 Mark Wendland 和 Mark Toomey 并肩作战</em></p>
</div><p>NEW YORK--(BUSINESS WIRE)--Tharimmune, Inc. (NASDAQ: THAR) (“Tharimmune” or the “Company”), the first publicly traded company to leverage Canton Coin (“CC”) to support the Canton Network’s ability to digitize traditional financial markets, today announced the appointment of seasoned financial executive Jacob Asbury as Chief Financial Officer, effective immediately. In this role, he will oversee all financial strategy and operations, including capital planning, treasury management, financial reporting, and the continued expansion of Tharimmune’s CC treasury infrastructure.</p>
<div class="lb-trans"><p>纽约 --（商业资讯）--Tharimmune, Inc.（纳斯达克：THAR）（“Tharimmune” 或 “公司”），首家利用 Canton Coin（“CC”）支持 Canton Network 数字化传统金融市场的上市公司，今天宣布任命经验丰富的金融高管 Jacob Asbury 为首席财务官，立即生效。在此角色中，他将负责所有财务战略和运营，包括资本规划、财务管理、财务报告，以及 Tharimmune CC 财务基础设施的持续扩展。</p>
</div><p>Mr. Asbury brings nearly two decades of financial leadership across capital markets, brokerage, and fintech. Following his tenure as CFO of Clear Street Group, Inc., Mr. Asbury led an independent advisory practice focused on financial systems implementation, reporting optimization, and process automation. Earlier in his career, Mr. Asbury held CFO roles at Performance Flight &amp; Custom Jet Charters and Instinet Incorporated. He holds a B.S. degree from the University of Vermont.</p>
<div class="lb-trans"><p>Asbury 先生在资本市场、经纪和金融科技领域拥有近二十年的财务领导经验。在担任 Clear Street Group, Inc.的首席财务官后，Asbury 先生领导了一家独立顾问公司，专注于财务系统实施、报告优化和流程自动化。在职业生涯早期，Asbury 先生曾担任 Performance Flight &amp; Custom Jet Charters 和 Instinet Incorporated 的首席财务官。他拥有佛蒙特大学的学士学位。</p>
</div><p>“Jacob’s deep financial leadership experience and a track record of delivering innovative approaches to financial operations, which is critical to our ability to create value for shareholders through our digital asset treasury strategy,” said Mark Wendland, CEO of Tharimmune, Inc. “With his strong roots in capital markets and his unique perspective as an operator, Jacob’s appointment signals our continued commitment to building the future rails of markets infrastructure through the Canton Network.”</p>
<div class="lb-trans"><p>“Jacob 在财务领导方面的深厚经验以及在财务运营中提供创新方法的记录，对于我们通过数字资产财务战略为股东创造价值至关重要，” Tharimmune, Inc.首席执行官 Mark Wendland 表示。“凭借他在资本市场的深厚根基和作为运营者的独特视角，Jacob 的任命标志着我们继续致力于通过 Canton Network 构建市场基础设施未来的承诺。”</p>
</div><p>Mr. Asbury added, “The Canton Network has the ability to transform how financial markets operate, and Tharimmune has positioned itself at the forefront of this evolution. I am proud to join a differentiated leadership team and look forward to leveraging my experience to help the Company advance these efforts and create long-term value for both shareholders and the Canton community.”</p>
<div class="lb-trans"><p>Asbury 先生补充道：“Canton Network 有能力改变金融市场的运作方式，而 Tharimmune 已在这一演变的前沿。我很自豪能加入一个与众不同的领导团队，并期待利用我的经验帮助公司推进这些努力，为股东和 Canton 社区创造长期价值。”</p>
</div><p>Tharimmune established its differentiated digital asset treasury (“DAT”) strategy in November 2025, driving value not only by acquiring CC, but also by applying to operate as a Super Validator and investing in applications built on the Canton Network that accelerate institutional utility and adoption across capital markets. Tharimmune is the first and only publicly traded company supported by the Canton Foundation.</p>
<div class="lb-trans"><p>Tharimmune 于 2025 年 11 月建立了其独特的数字资产财务（“DAT”）战略，不仅通过收购 CC 来驱动价值，还申请作为超级验证者运营，并投资于在 Canton Network 上构建的应用程序，以加速资本市场的机构效用和采用。Tharimmune 是首家也是唯一一家获得 Canton Foundation 支持的上市公司。</p>
</div><p><strong>About Tharimmune</strong></p>
<div class="lb-trans"><p><strong>关于 Tharimmune</strong></p>
</div><p>Tharimmune, Inc. (NASDAQ: THAR) is the first publicly traded company to leverage Canton Coin and support the Canton Network to advance institutional blockchain adoption and the digitization of financial markets. In addition to driving value through activities on the Canton Network, Tharimmune also operates clinical-stage biotech research and development. For more information, visit: www.tharimmune.com.</p>
<div class="lb-trans"><p>Tharimmune, Inc.（纳斯达克：THAR）是首家利用 Canton Coin 并支持 Canton Network 以推动机构区块链采用和金融市场数字化的上市公司。除了通过在 Canton Network 上的活动驱动价值外，Tharimmune 还从事临床阶段的生物技术研究和开发。欲了解更多信息，请访问：www.tharimmune.com。</p>
</div><p><strong>Cautionary Note Regarding Forward-Looking Statements</strong></p>
<div class="lb-trans"><p><strong>关于前瞻性声明的警示说明</strong></p>
</div><p>This press release contains statements that constitute “forward-looking statements” within the meaning of the U.S. federal securities laws. Forward-looking statements are statements other than historical facts and include, without limitation, statements regarding the potential for and amount of additional cash proceeds from warrant exercises, the anticipated use of proceeds from the announced Offering, future stockholder approvals, future announcements and priorities, expectations regarding management, corporate governance, market position, business strategies, future financial and operating performance, and other projections or statements of plans and objectives.</p>
<div class="lb-trans"><p>本新闻稿包含根据美国联邦证券法构成的 “前瞻性声明”。前瞻性声明是指除历史事实之外的陈述，包括但不限于关于认股权证行使的潜在和额外现金收益的金额、宣布的发行的预期收益使用、未来股东批准、未来公告和优先事项、对管理、公司治理、市场地位、商业战略、未来财务和运营表现的期望，以及其他计划和目标的预测或声明。</p>
</div><p>These forward-looking statements are based on current expectations, estimates, assumptions, and projections, and involve known and unknown risks, uncertainties, and other factors—many of which are beyond the Company’s control—that may cause actual results, performance, or achievements to differ materially from those expressed or implied by such statements. Important factors that may affect actual results include, among others, the Company’s ability to execute its growth strategy; its ability to raise and deploy capital effectively; developments in technology and the competitive landscape; the market performance of CC; and other risks and uncertainties described under “Risk Factors” in the Company’s Annual Report on Form 10-K filed with the SEC on March 26, 2025, and in other subsequent filings with the SEC. These filings are available at www.sec.gov. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law.</p>
<div class="lb-trans"><p>这些前瞻性声明基于当前的预期、估计、假设和预测，并涉及已知和未知的风险、不确定性和其他因素——其中许多超出了公司的控制——可能导致实际结果、表现或成就与这些声明所表达或暗示的结果有重大差异。可能影响实际结果的重要因素包括但不限于公司的增长战略执行能力；有效筹集和部署资本的能力；技术和竞争环境的发展；CC 的市场表现；以及在 2025 年 3 月 26 日向 SEC 提交的公司 10-K 年度报告及其他后续文件中描述的其他风险和不确定性。这些文件可在 www.sec.gov 获取。公司没有义务更新或修订任何前瞻性声明，无论是由于新信息、未来事件还是其他原因，法律要求的除外。</p>
</div><p><strong>Twitter/X:</strong>@TharimmuneInc</p>
<div class="lb-trans"><p><strong>Twitter/X:</strong>@TharimmuneInc</p>
</div><p><strong>Website:</strong> https://tharimmune.com/</p>
<div class="lb-trans"><p><strong>网站：</strong> https://tharimmune.com/</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://cts.businesswire.com/ct/CT/query-ZGlzdHJvPW54JmlkPWJ3bmV3cyZsYW5nPWVuJnNpZD1hY3FyOCZzdHk9MjAyNTEyMTI4NDE3MTZyMQ" alt="" original-src="https://cts.businesswire.com/ct/CT?id=bwnews&amp;sty=20251212841716r1&amp;sid=acqr8&amp;distro=nx&amp;lang=en"/></p>
<p>View source version on businesswire.com: https://www.businesswire.com/news/home/20251212841716/en/</p>
<div class="lb-trans"><p>在 businesswire.com 查看源版本：https://www.businesswire.com/news/home/20251212841716/en/</p>
</div><p>Media:</p>
<div class="lb-trans"><p>媒体：</p>
</div><p>Gasthalter &amp; Co.</p>
<div class="lb-trans"><p>Gasthalter &amp; Co.</p>
</div><p>(212) 257-4170</p>
<div class="lb-trans"><p>（212）257-4170</p>
</div><p>canton@gasthalter.com</p>
<div class="lb-trans"><p>canton@gasthalter.com</p>
</div><p>Investors:</p>
<div class="lb-trans"><p>投资者：</p>
</div><p>ir@tharimmune.com</p>
<div class="lb-trans"><p>ir@tharimmune.com</p>
</div><p>Source: Tharimmune, Inc.</p>
<div class="lb-trans"><p>来源：Tharimmune, Inc.</p>
</div>

Tharimmune 公司任命 Jacob Asbury 为首席财务官，以推进 Canton Coin 财政战略 | THAR 股票新闻